Daily Stock Analysis, ANIK, Anika Therapeutics Inc, priceseries

Anika Therapeutics Inc. Daily Stock Analysis
Stock Information
Open
31.00
Close
31.64
High
31.71
Low
30.96
Previous Close
31.16
Daily Price Gain
0.48
YTD High
40.71
YTD High Date
Feb 21, 2019
YTD Low
29.01
YTD Low Date
Mar 27, 2019
YTD Price Change
-2.88
YTD Gain
-8.34%
52 Week High
46.59
52 Week High Date
May 2, 2018
52 Week Low
28.54
52 Week Low Date
Jun 20, 2018
52 Week Price Change
-13.49
52 Week Gain
-29.89%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 19. 2018
59.03
Feb 2. 2018
64.68
10 Trading Days
9.58%
Link
LONG
Dec 28. 2018
31.94
Jan 10. 2019
33.61
8 Trading Days
5.22%
Link
LONG
Jan 15. 2019
34.09
Feb 22. 2019
37.27
26 Trading Days
9.33%
Link
Company Information
Stock Symbol
ANIK
Exchange
NasdaqGS
Company URL
http://www.anikatherapeutics.com
Company Phone
(781) 457-9000
CEO
Charles H. Sherwood
Headquarters
Massachusetts
Business Address
32 WIGGINS AVENUE, BEDFORD, MA 01730
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000898437
About

Anika Therapeutics, Inc. is global medical technology company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration and wound healing. The company's products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical and veterinary. Anika Therapeutics was founded in 1992 and is headquartered in Bedford, MA.

Description

Anika Therapeutics, Inc., together with its subsidiaries, provides orthopedic medicines for patients with degenerative orthopedic diseases and traumatic conditions in the United States and internationally. The company develops, manufactures, and commercializes therapeutic products based on its proprietary hyaluronic acid (HA) technology. Its orthobiologics products comprise ORTHOVISC, ORTHOVISC mini, MONOVISC, and CINGAL for the treatment of osteoarthritis of the knee; HYALOFAST, a biodegradable support for human bone marrow mesenchymal stem cells used for cartilage regeneration and as an adjunct for microfracture surgery; HYALONECT, a woven gauze used as a bone graft wrap; HYALOSS used to mix blood/bone grafts to form a paste for bone regeneration; and HYALOGLIDE, an ACP gel used in tenolysis treatment. The company's dermal products include wound care products that comprise HYALOMATRIX and HYALOFILL for the treatment of complex wounds, such as burns and ulcers, and for use in connection with the regeneration of skin; and ELEVESS, an aesthetic dermatology product. Its surgical products comprise HYALOBARRIER, a post-operative adhesion barrier for use in the abdomino-pelvic area; INCERT, a HA product used for the prevention of post-surgical spinal adhesions; MEROGEL, a woven fleece nasal packing; and MEROGEL INJECTABLE, a viscous hydrogel. The company also offers ophthalmic products, including injectable HA products that are used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation; and veterinary products, which include HYVISC, an injectable HA product for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.